Effectiveness of Epidural Anesthesia for External Cephalic Version (ECV)

Total Page:16

File Type:pdf, Size:1020Kb

Effectiveness of Epidural Anesthesia for External Cephalic Version (ECV) Journal of Perinatology (2010) 30, 580–583 r 2010 Nature America, Inc. All rights reserved. 0743-8346/10 www.nature.com/jp ORIGINAL ARTICLE Effectiveness of epidural anesthesia for external cephalic version (ECV) M Yoshida, H Matsuda, Y Kawakami, Y Hasegawa, Y Yoshinaga, E Hayata, K Asai, A Kawashima and K Furuya Department of Obstetrics and Gynecology, National Defense Medical College, Saitama, Japan Journal of Perinatology (2010) 30, 580–583; doi:10.1038/jp.2010.61; Objective: The Cochrane review conducted in 2001 re-established the published online 20 May 2010 usefulness of external cephalic version (ECV). The success rate for ECV using epidural anesthesia or spinal anesthesia is reported to be 35 to 86%. Keywords: breech presentation; external cephalic version; epidural In this study, we examined the effectiveness of epidural anesthesia for ECV. anesthesia Study Design: A retrospective cohort study was conducted of pregnant women who were at 35 to 36 weeks of gestation between 2001 and June 2009, with a single fetus, non-cephalic presentation and without non- Introduction reassuring fetal status. The subjects were ultrasonographically examined Breech presentation at term occurs in 3 to 4% of all pregnancies.1 for placental location, presence/absence of nuchal cord and amniotic fluid In case of breech presentation, it has been shown that selective volume. Those with placenta previa, early rupture of membranes, uterine cesarean delivery provides a better perinatal prognosis for anomaly or severe fetal anomaly and those in whom delivery was initiated children than vaginal delivery.2–4 The Cochrane review in 2001 were excluded from the study. The study protocol was approved by the re-established the usefulness of external cephalic version (ECV). institutional ethics committee, and written informed consent was obtained The American Congress of Obstetricians and Gynecologists for all procedures described in the protocol. The success rate for ECV was Committee has also recommended reducing breech presentation.3 compared between the anesthesia and non-anesthesia groups. Analysis was On the basis of these suggestions, we are proposing to our patients also performed to identify factors contributing to successful ECV. the use of ECV as the third option, in addition to the choice of Result: There were 86 women with non-cephalic presentation who either trial breech delivery or selective cesarean delivery. 5 underwent ECV during the study period. The non-anesthesia group Mancuso et al. have reported the effectiveness of epidural consisted of 34 women in whom ritodrine hydrochloride, a tocolytic agent, anesthesia for ECV for breech presentation in late pregnancy. The was administered alone, and 52 women in whom a tocolytic agent and success rate of ECV with epidural anesthesia was 59.2%. We began epidural anesthesia were used constituted the anesthesia group. There using epidural anesthesia for ECV since 2003. This study intends to were no significant differences between the two groups in terms of age, examine its effectiveness for success of ECV. parity, body mass index and placental location. The success rate for ECV was 55.9% (19/34 patients) in the non-anesthesia group and 78.8% (41/52 patients) in the anesthesia group, showing a significant difference Methods between the two groups (odds ratio 1.75, 95% confidence interval 1.26 to The study was carried out at National Defense Medical College 2.44). Analysis was also performed to identify factors determining Hospital between 1 January 2001 and 30 June 2009. The study successful ECV other than epidural anesthesia from among age, parity, protocol was approved by the institutional ethics committee, and body mass index, placental location, presence/absence of uterine myoma, written informed consent was obtained for all procedures described nuchal code and previous cesarean delivery; however, none of the factors in the protocol. Pregnant women meeting the following criteria identified was found to be a significant determinant factor. were selected as the study subjects: 35 to 36 weeks of gestation, Conclusion: The use of epidural anesthesia significantly increases the breech or transverse presentation, single pregnancy, aged X18 success rate for ECV for breech presentation. years, showing a reassuring fetal status pattern in the non-stress test and estimated fetal weight of 2000 to 4000 g. The subjects were Correspondence: Dr M Yoshida, Department of Obstetrics and Gynecology, National Defense hospitalized and ultrasonographically examined for placental Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513 Japan. location, umbilical insertion site, presence/absence of uterine E-mail: [email protected] Received 18 September 2009; revised 15 March 2010; accepted 11 April 2010; published online myoma, anomaly and nuchal cord. Those with placenta previa, 20 May 2010 early rupture of membranes, uterine anomaly or severe fetal Does ECV need epidural anesthesia? M Yoshida et al 581 anomaly and those in whom delivery was initiated were excluded Table 1 Study characteristics from the study. Anesthesia Non-anesthesia P-value Before ECV, each subject was intravenously administered 500 ml group group of hydroxyethylated starch for the expansion of circulating plasma (n ¼ 52) (n ¼ 34) volume and continuously administered ritodrine hydrochloride as a tocolytic agent at a rate of 67 mg min–1. In the anesthesia group, Age (years) 31.9±4.7 29.5±5.1 0.168 an epidural catheter was inserted at the L1/L2 intervertebral space, Nullipara 21 (40.4%) 13 (38.2%) 0.662 –2 followed by the administration of 3 ml of 0.25% bupivacaine. After BMI (kg m ) 25.4±3.8 23.8±2.0 0.112 confirming the absence of adverse reactions such as a decrease in Placental location blood pressure, another 10 ml of 0.25% bupivacaine was infused. Anterior 29 (55.8%) 21 (61.8%) 0.449 Blood pressure was monitored every 1 min during the first 10 min Posterior 23 (44.2%) 13 (38.2%) after drug administration, then every 2 min for another 10 min Uterine myoma 2 (3.8%) 2 (5.9%) 0.572 and every 5 min thereafter. Each subject was placed in the Nucal cord 2 (3.8%) 1 (2.9%) 0.324 Trendelenburg position after the level of anesthesia reached T10. Gestational week at ECV (weeks)a 36.2±0.6 35.8±0.9 0.112 An obstetrician stood on the right-hand side of a subject when Estimated fetal body weight at ECV (g)a 2436±264 2451±251 0.812 performing ECV. ECV was basically performed by forward rotation, Gestational week at birth (weeks)a 38.8±1.7 38.8±1.6 0.426 and if it failed, by backward rotation. No limitation was set on the Birth weight (g)a 2969±442 2882±452 0.168 procedural time. We did not perform a transvaginal fetus-lifting Apgar score (5 min)a 9.4±0.9 9.5±0.6 0.334 procedure in any of the patients. When a resident physician was to Abbreviations: BMI, body mass index; ECV, external cephalic version. perform ECV, he or she was supervised by a senior attending aMean±s.d. physician. After completion of ECV, the mother and fetus were evaluated for approximately 4 h. Fetal well-being was evaluated using (41/52 patients) in the anesthesia group, showing a significant the non-stress test before and after ECV. If ECV failed, cesarean difference between the two groups (odds ratio 1.75, 95% confidence delivery was then scheduled for approximately 38 weeks of gestation. interval 1.26 to 2.44). There was no case of non-reassuring fetal From 2001 to 2003, we used just the tocolytic agent in the status immediately after ECV in either of the groups. In the setting of ECV. Subsequent to 2003, we began using epidural non-anesthesia group, 1 of the 19 patients with successful ECV anesthesia, and this constituted the primary difference between our developed uterine infection and thus underwent cesarean delivery. two groups. The anesthesia and non-anesthesia groups were In the anesthesia group, 6 of the 41 patients with successful compared in terms of the rate of vaginal delivery, overall rate of ECV underwent cesarean delivery. The reasons included cesarean delivery and rate of neonatal asphyxia. occipitoposterior presentation during delivery in four patients, Statistical analyses were performed using Student’s t-test and the non-reassuring fetal status during delivery in one patient and w2 test. Logistic regression was used for multivariate analysis to adjust recurrence of breech presentation in one patient. The overall rate for potential confounding factors (Statview, version 5.0, SAS Institute of cesarean delivery as a measure of delivery outcome was 50.0% Inc., Cary, NC, USA). P<0.05 was statistically significant. Because of (17/34 patients) in the non-anesthesia group and 32.7% the natural experiment nature of this study with a specific convenience (17/52 patients) in the anesthesia group, not indicating a sample, we did not conduct any apriorisample size calculations. significant contribution of ECV to the reduction of cesarean delivery (odds ratio 0.49, 95% confidence interval 0.23 to 1.18). There was no case of neonatal asphyxia during delivery or transient Results tachypnea of the newborn after delivery in either of the groups. During the study period, 86 women with non-cephalic presentation Univariate analysis of the potential effect of different variables were eligible for ECV and were included in the study. The non- on success rates of ECV is shown in Table 3. Maternal age, parity, anesthesia group consisted of 34 women who underwent ECV body mass index, placental location and epidural anesthesia were between January 2001 and March 2003, in whom ritodrine significant at P<0.05. Multivariate analysis found that none of the hydrochloride, a tocolytic agent, was administered alone, and 52 factors had statistically significant effects of ECV success rates women who underwent ECV between April 2003 and June 2009, in except for epidural anesthesia (Table 4).
Recommended publications
  • Delivery Mode for Prolonged, Obstructed Labour Resulting in Obstetric Fistula: a Etrr Ospective Review of 4396 Women in East and Central Africa
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by eCommons@AKU eCommons@AKU Obstetrics and Gynaecology, East Africa Medical College, East Africa 12-17-2019 Delivery mode for prolonged, obstructed labour resulting in obstetric fistula: a etrr ospective review of 4396 women in East and Central Africa C. J. Ngongo T. J. Raassen L. Lombard J van Roosmalen S. Weyers See next page for additional authors Follow this and additional works at: https://ecommons.aku.edu/eastafrica_fhs_mc_obstet_gynaecol Part of the Obstetrics and Gynecology Commons Authors C. J. Ngongo, T. J. Raassen, L. Lombard, J van Roosmalen, S. Weyers, and Marleen Temmerman DOI: 10.1111/1471-0528.16047 www.bjog.org Delivery mode for prolonged, obstructed labour resulting in obstetric fistula: a retrospective review of 4396 women in East and Central Africa CJ Ngongo,a TJIP Raassen,b L Lombard,c J van Roosmalen,d,e S Weyers,f M Temmermang,h a RTI International, Seattle, WA, USA b Nairobi, Kenya c Cape Town, South Africa d Athena Institute VU University Amsterdam, Amsterdam, The Netherlands e Leiden University Medical Centre, Leiden, The Netherlands f Department of Obstetrics and Gynaecology, Ghent University Hospital, Ghent, Belgium g Centre of Excellence in Women and Child Health, Aga Khan University, Nairobi, Kenya h Faculty of Medicine and Health Science, Ghent University, Ghent, Belgium Correspondence: CJ Ngongo, RTI International, 119 S Main Street, Suite 220, Seattle, WA 98104, USA. Email: [email protected] Accepted 3 December 2019. Objective To evaluate the mode of delivery and stillbirth rates increase occurred at the expense of assisted vaginal delivery over time among women with obstetric fistula.
    [Show full text]
  • A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
    ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction ..............................................................................................................
    [Show full text]
  • Clinical and Physical Aspects of Obstetric Vacuum Extraction
    CLINICAL AND PHYSICAL ASPECTS OF OBSTETRIC VACUUM EXTRACTION KLINISCHE EN FYSISCHE ASPECTEN VAN OnSTETRISCHE VACUUM EXTRACTIE Clinical and physical aspects of obstetric vacuum extraction I Jette A. Kuit Thesis Rotterdam - with ref. - with summary in Dutch ISBN 90-9010352-X Keywords Obstetric vacuum extraction, oblique traction, rigid cup, pliable cup, fetal complications, neonatal retinal hemorrhage, forceps delivery Copyright Jette A. Kuit, Rotterdam, 1997. All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the holder of the copyright. Cover, and drawings in the thesis, by the author. CLINICAL AND PHYSICAL ASPECTS OF OBSTETRIC VACUUM EXTRACTION KLINISCHE EN FYSISCHE ASPECTEN VAN OBSTETRISCHE VACUUM EXTRACTIE PROEFSCHRIFf TER VERKRUGING VAN DE GRAAD VAN DOCTOR AAN DE ERASMUS UNIVERSITEIT ROTTERDAM OP GEZAG VAN DE RECTOR MAGNIFICUS PROF. DR. P.W.C. AKKERMANS M.A. EN VOLGENS BESLUIT VAN HET COLLEGE VOOR PROMOTIES DE OPENBARE VERDEDIGING ZAL PLAATSVINDEN OP WOENSDAG 2 APRIL 1997 OM 15.45 UUR DOOR JETTE ALBERT KUIT GEBOREN TE APELDOORN Promotiecommissie Promotor Prof.dr. H.C.S. Wallenburg Overige leden Prof.dr. A.C. Drogendijk Prof. dr. G.G.M. Essed Prof.dr.ir. C.l. Snijders Co-promotor Dr. F.J.M. Huikeshoven To my parents, to Irma, Suze and Julius. CONTENTS 1. GENERAL INTRODUCTION 9 2. VACUUM CUPS AND VACUUM EXTRACTION; A REVIEW 13 2.1. Introduction 2.2. Obstetric vacuum cups in past and present 2.2.1. Historical backgroulld 2.2.2.
    [Show full text]
  • Leapfrog Hospital Survey Hard Copy
    Leapfrog Hospital Survey Hard Copy QUESTIONS & REPORTING PERIODS ENDNOTES MEASURE SPECIFICATIONS FAQS Table of Contents Welcome to the 2016 Leapfrog Hospital Survey........................................................................................... 6 Important Notes about the 2016 Survey ............................................................................................ 6 Overview of the 2016 Leapfrog Hospital Survey ................................................................................ 7 Pre-Submission Checklist .................................................................................................................. 9 Instructions for Submitting a Leapfrog Hospital Survey ................................................................... 10 Helpful Tips for Verifying Submission ......................................................................................... 11 Tips for updating or correcting a previously submitted Leapfrog Hospital Survey ...................... 11 Deadlines ......................................................................................................................................... 13 Deadlines for the 2016 Leapfrog Hospital Survey ...................................................................... 13 Deadlines Related to the Hospital Safety Score ......................................................................... 13 Technical Assistance.......................................................................................................................
    [Show full text]
  • Facility Worksheet for Newborn Registration to Be Completed by Facility Staff
    New York City Department of Health and Mental Hygiene Bureau of Vital Statistics Facility Worksheet for Newborn Registration To be completed by Facility Staff • This worksheet contains items to be completed by the facility staff. Items in GREEN will be provided by the Mother/Parent and should be entered into the Electronic Birth Registration System (EBRS) from the Mother/ Parent’s Worksheet. If ALL items on a specific EBRS Screen are from the Mother/Parent’s worksheet, instructions will indicate: See MOTHER/PARENT’S WORKSHEET for all items on this screen. • The items on the Mother/Parent’s Worksheet and this Facility Worksheet are listed in order of the EBRS data entry screens. Please follow the instructions below to obtain and enter accurate data into EBRS. For Facility Birth Registration Tracking Purposes Mother/Parent’s Name: Number delivered this pregnancy If more than one, birth order of this child SCREEN: START A NEW CASE Child’s Last Name Date of Once you have completed the form below, you Child’s (found on Monther’s Worksheet) ___ ___ / ___ ___ / ___ ___ ___ ___ Birth will be ready to Start a New Case in EBRS. Month Day Year You must have the following information to Child’s Sex Female Mother/Parent’s Medical Child’s Medical Male Record Number Record Number start a new case: Undetermined SCREEN: CHILD Name of Child Date of Child’s Birth Time of Child’s Social Security number for Child? Safe Haven / Foundling Baby AM No military (Last name (and any other name) is automatically filled from Start New Case Screen) (Automatically
    [Show full text]
  • • Chapter 8 • Nursing Care of Women with Complications During Labor and Birth • Obstetric Procedures • Amnioinfusion –
    • Chapter 8 • Nursing Care of Women with Complications During Labor and Birth • Obstetric Procedures • Amnioinfusion – Oligohydramnios – Umbilical cord compression – Reduction of recurrent variable decelerations – Dilution of meconium-stained amniotic fluid – Replaces the “cushion ” for the umbilical cord and relieves the variable decelerations • Obstetric Procedures (cont.) • Amniotomy – The artificial rupture of membranes – Done to stimulate or enhance contractions – Commits the woman to delivery – Stimulates prostaglandin secretion – Complications • Prolapse of the umbilical cord • Infection • Abruptio placentae • Obstetric Procedures (cont.) • Observe for complications post-amniotomy – Fetal heart rate outside normal range (110-160 beats/min) suggests umbilical cord prolapse – Observe color, odor, amount, and character of amniotic fluid – Woman ’s temperature 38 ° C (100.4 ° F) or higher is suggestive of infection – Green fluid may indicate that the fetus has passed a meconium stool • Nursing Tip • Observe for wet underpads and linens after the membranes rupture. Change them as often as needed to keep the woman relatively dry and to reduce the risk for infection or skin breakdown. • Induction or Augmentation of Labor • Induction is the initiation of labor before it begins naturally • Augmentation is the stimulation of contractions after they have begun naturally • Indications for Labor Induction • Gestational hypertension • Ruptured membranes without spontaneous onset of labor • Infection within the uterus • Medical problems in the
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • Operative Vaginal Delivery
    FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM CHAPTER 18 OPERATIVE VAGINAL DELIVERY Learning Objectives By the end of this chapter, the participant will: 1. Compare and contrast the methods available for operative vaginal delivery including the benefits, risks and indications for each method. 2. Describe the mnemonic for the safe use of vacuum and forceps for operative vaginal delivery. 3. Describe the appropriate documentation that should be recorded after every operative vaginal delivery. Introduction Operative vaginal delivery refers to the use of a vacuum or forceps in vaginal deliveries. Both methods are safe and reliable for assisting childbirth, if appropriate attention is paid to the indications and contraindications for the procedures. The benefits and risks to both the woman and her fetus of using either instrument or the risks associated with proceeding to the alternative of cesarean section delivery must be considered in every case. The choice of instrument should suit both the clinical circumstances, the skill of the health care provider and the acceptance of the woman. The health care provider should have training, experience and judgmental ability with the instrument chosen. Informed consent is an essential step in preparing for an operative vaginal delivery. Operative vaginal delivery should be avoided in women who are HIV positive to reduce mother-to-child transmission. If forceps or vacuum is necessary, avoid performing an episiotomy. Assessing the Descent of the Baby Prior to performing an operative delivery, it is essential to determine that the vertex is fully engaged. Descent of the baby may be assessed abdominally or vaginally. When there is a significant degree of caput (swelling) or molding (overlapping of the fetal skull bones), assessment by abdominal palpation using ―fifths of head palpable‖ is more useful than assessment by vaginal examination.
    [Show full text]
  • Vacuum Extraction and Forceps Deliveries; Comparison of Maternal and Neonatal Complications
    VACUUM EXTRACTION AND FORCEPS DELIVERIES 87 ORIGINAL PROF-1235 VACUUM EXTRACTION AND FORCEPS DELIVERIES; COMPARISON OF MATERNAL AND NEONATAL COMPLICATIONS DR. ALIYA ISLAM DR. JAVARIA NOSHEEN MURTAZA Military Hospital Rawalpindi Military Hospital Rawalpindi DR. AISHA HANIF KHAN Military Hospital Rawalpindi ABSTRACT... Objective: To compare the maternal and neonatal complications after instrumental deliveries. Design: Prospective study. Setting: At MH Rawalpindi. Period: Six months from April 15, 2006 to October 14, 2006. Results: Total 96 instrumental deliveries were carried out; of which 46 were ventouse and 50 were forceps deliveries. 58% of forceps deliveries were carried out in nulliparous and 42% in mulitparous patients as compared to 61% of ventouse deliveries in nulliparous and 39% in multiparous patients. Fetal distress was indication in 68% of forceps deliveries and 61% ventouse deliveries. Prolong second stage (>1 hr) was the second commonest indication i.e., in 18% of forceps deliveries and 13% of ventouse deliveries. Success rate was 90% in ventouse and 97% in forceps deliveries. Extension of episiotomy was more likely to occur with ventouse deliveries and third degree perineal tear occurred more with forceps deliveries. 14 babies were admitted to NICU and 90% of them were due to meconium staining. There was only one intrapartum death in the ventouse delivery group and that was due to intrapartum asphyxia. Conclusion: Forceps are more likely to be used in primigravidas and less likely to fail. Most common indication of instrumental deliveries is fetal distress followed by prolonged second stage. Cephalhaematoma and jaundice are more common in ventouse deliveries. Extension of episiotomy and low apgar score at one minute is more likely to occur with ventouse deliveries where as third degree perineal tear and subconjuctival haemorrhage are more likely to occur in forceps deliveries.
    [Show full text]
  • Case History for Pregnant Mothers
    Case History for Pregnant Mothers Name: _________________________________________ Previous chiropractic care? ____________________ Who referred you here? ________________________ Prenatal history: 1) Is this your first pregnancy? 2) How many other births have you had? 3) How many weeks pregnant are you now? 4) Have you experienced any traumas during this pregnancy (accidents, falls)? Please describe: 5) Any medications taken during this pregnancy? 6) Do you smoke or drink alcohol? 7) Have you had any evaluation procedures (ultrasound, amniocentesis, chorionic villus sampling)? 8) Please list dates, frequency and reason for these procedures: 9) How has your diet been during this pregnancy? 10) Have there been any stressful events in your life during this pregnancy? 11) What are your most significant fears associated with this birth? 12) Who is your birth care provider? 13) Will you have someone with you at birth for support (other than birth care provider)? Please specify who: 14) Where do you plan on delivering? 15) Have you put together a birth plan? Previous Birth History: 1) Place of birth: hospital, birthing center, home 2) Delivering Practitioner: OB/Gyn, Certified Nurse Midwife, Certified Practicing Midwife, Lay Midwife 3) Position of Delivery: Lithotomy position (on back with feet up), On your side, Kneeling, Squatting, Other? 4) Was labor induced? (Contractions were stimulated prior to the natural onset of labor) Yes No Unknown 5) Were your membranes ruptured by your care provider? Yes No Unknown 6) Were contractions stimulated
    [Show full text]
  • VACUUM-ASSISTED DELIVERY Improving Patient Outcomes and Protecting Yourself Against Litigation
    OBGMANAGEMENT A SUPPLEMENT TO OBG MANAGEMENT, FEBRUARY 2004 VACUUM-ASSISTED DELIVERY Improving patient outcomes and protecting yourself against litigation VACUUM-ASSISTED DELIVERY Practical techniques to improve patient outcomes I by Aldo Vacca, MD b/Gyns in general prefer vacuum-assisted delivery (VAD) over forceps-assisted delivery, although increased usage has also Obeen associated with more frequent reports of adverse out- comes.1,2 Attention to the details of technique can help prevent prob- lems and ensure the best patient outcomes. This supplement to THE FLEXION POINT: OBG MANAGEMENT serves as a A CRITICAL LANDMARK FOR VAD companion to Preserving the The fetal head is in complete flexion when the mentovertical diameter Option of Vacuum Extraction, points in the direction of descent (Figure 1). During deliveries in which an article appearing in the February 2004 issue. the fetal head is normally molded, the mentovertical diameter emerges on the sagittal suture approximately 3 cm anterior to the posterior fontanelle.4 This flexion point is a critical landmark for VAD; when the center of the extraction cup has been placed over the flexion point and axis traction is applied, conditions are optimal for delivery (Figure 2). Contents 1 VACUUM-ASSISTED DELIVERY Aldo Vacca, MD, Editor Disclosures Practical techniques to improve Associate Professor of Dr Vacca serves on the speaker’s Obstetrics and Gynecology bureau for Clinical Innovations, patient outcomes The University of Queensland Inc. Drs Billings and Vines I by Aldo Vacca, MD Brisbane, Australia have no commercial relationships to disclose. R. Gail Billings, PhD THE PHYSICS OF VACUUM EXTRACTION 7 Senior Research Scientist This supplement is supported Medical Physics Proper use of compression and traction by a grant from Clinical Salt Lake City, Utah for better patient outcomes Innovations, Inc.
    [Show full text]
  • Complicated Vacuum Extraction Delivery: Focus on Traction Force
    DEPARTMENT OF CLINICAL SCIENCE, INTERVENTION AND TECHNOLOGY Karolinska Institutet, Stockholm, Sweden COMPLICATED VACUUM EXTRACTION DELIVERY: FOCUS ON TRACTION FORCE Kristina Pettersson Stockholm 2018 All previously published papers were reproduced with permission from the publisher. Original illustrations by Ellen Anderberg Published by Karolinska Institutet. Printed by E-print AB 2018 © Kristina Pettersson, 2018 ISBN 978-91-7831-175-0 Complicated vacuum extraction delivery: focus on traction force THESIS FOR DOCTORAL DEGREE (Ph.D.) To be publicly defended in lecture hall B64 , Karolinska university hospital, Huddinge Friday November 16th at 9.00 By Kristina Pettersson Principal Supervisor: Opponent: MD PhD Gunilla Ajne Professor Marie Blomberg Karolinska Institutet Linköping university Department of clinical science, intervention and Department of clinical science and experimental technology medicine Division of obstetrics and gynecology Examination Board: Co-supervisor(s): Professor Ellika Andolf Professor Magnus Westgren Karolinska institutet, Danderyd Karolinska Institutet Department of clinical science Department of clinical science, intervention and technology Associate professor Stefan Johansson Division of obstetrics and gynecology Karolinska institutet Department of clinical science and education Professor Mats Blennow Karolinska Institutet Associate professor Maria Jonsson Department of clinical science, intervention and Uppsala university technology Department of women and children´s health Division of pediatrics ABSTRACT Introduction Vacuum extraction is a common operative vaginal delivery in the final stage of labor, and generally considered a safe alternative to emergency cesarean section. However, there is insufficient evidence regarding the causes of the rare but severe perinatal complications that may occur, such as intracranial or subgaleal hemorrhage, and possibly also asphyxia related encephalopathy. High levels of traction force and failed extraction are two suggested risk factors for adverse neonatal outcome.
    [Show full text]